Genelux (GNLX) Change in Acquisitions & Divestments (2024 - 2026)
Genelux's (GNLX) quarterly Change in Acquisitions & Divestments came in at $6.8 million in Q1 2026, up 13.0% year-on-year from $6.0 million in Q1 2025, and down 3.14% quarter-over-quarter from $7.0 million in Q4 2025.
Genelux (GNLX) Change in Acquisitions & Divestments (2024 - 2026) Analysis & Trends
Genelux's Change in Acquisitions & Divestments history runs 3 years deep, the most recent figure standing at $6.8 million for Q1 2026.
- On a quarterly basis, Change in Acquisitions & Divestments rose 13.0% year-over-year to $6.8 million in Q1 2026; TTM through Mar 2026 was $32.3 million, a 25.36% increase from a year earlier, with the FY2025 full-year figure at $31.5 million, up 48.24% from the prior year.
- Change in Acquisitions & Divestments declined to $6.8 million in Q1 2026 per GNLX's latest filing, from $7.0 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $10.5 million in Q3 2025 and bottomed at $1.5 million in Q1 2024.
- The 3-year median for Change in Acquisitions & Divestments is $6.8 million (2026), against an average of $6.6 million.
- Biggest YoY gain for Change in Acquisitions & Divestments was 300.0% in 2025; the steepest drop was 3.45% in 2025.
- Year by year, Change in Acquisitions & Divestments stood at $7.2 million in 2024, then dropped by 3.45% to $7.0 million in 2025, then slipped by 3.14% to $6.8 million in 2026.
- Per Business Quant, the three latest GNLX Change in Acquisitions & Divestments figures stand at $6.8 million (Q1 2026), $7.0 million (Q4 2025), and $10.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,538.84 Bn | 65,538.56 Bn | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 469.46 Bn | 464.67 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.69 Bn | 115.45 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.41 Bn | 61.65 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.84 Bn | 62.84 Bn | - |
| 8 | Argenx Se | 56.10 Bn | 50.91 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.48 Bn | 34.47 Bn | 959.66 Mn |
| 10 | Genelux | 128.92 Mn | 128.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.78 Mn |
| Mar 31, 2026 | 6.78 Mn |
| Dec 31, 2025 | 7.00 Mn |
| Dec 31, 2025 | 7.00 Mn |
| Sep 30, 2025 | 10.50 Mn |
| Sep 30, 2025 | 10.50 Mn |
| Jun 30, 2025 | 8.00 Mn |
| Jun 30, 2025 | 8.00 Mn |
| Mar 31, 2025 | 6.00 Mn |
| Mar 31, 2025 | 6.00 Mn |
| Dec 31, 2024 | 7.25 Mn |
| Dec 31, 2024 | 7.25 Mn |
| Sep 30, 2024 | 6.00 Mn |
| Sep 30, 2024 | 6.00 Mn |
| Jun 30, 2024 | 6.50 Mn |
| Jun 30, 2024 | 6.50 Mn |
| Mar 31, 2024 | 1.50 Mn |
| Mar 31, 2024 | 1.50 Mn |